These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 7811012

  • 1. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [Abstract] [Full Text] [Related]

  • 2. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A, Blanche F.
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [Abstract] [Full Text] [Related]

  • 3. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B, Hooper DC.
    Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
    [Abstract] [Full Text] [Related]

  • 4. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
    Ng EY, Trucksis M, Hooper DC.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1881-8. PubMed ID: 8843298
    [Abstract] [Full Text] [Related]

  • 5. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM, Grau O, Charron A, Renaudin H, Gruson D, Bébéar C.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.
    Onodera Y, Sato K.
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2423-9. PubMed ID: 10508019
    [Abstract] [Full Text] [Related]

  • 7. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [Abstract] [Full Text] [Related]

  • 8. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S, Hooper DC, Tankovic J, Soussy CJ.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [Abstract] [Full Text] [Related]

  • 9. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance.
    Hopewell R, Oram M, Briesewitz R, Fisher LM.
    J Bacteriol; 1990 Jun; 172(6):3481-4. PubMed ID: 2160946
    [Abstract] [Full Text] [Related]

  • 10. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [Abstract] [Full Text] [Related]

  • 11. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.
    Pan XS, Fisher LM.
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2810-6. PubMed ID: 9797208
    [Abstract] [Full Text] [Related]

  • 12. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.
    Yamagishi J, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue M.
    Antimicrob Agents Chemother; 1996 May; 40(5):1157-63. PubMed ID: 8723458
    [Abstract] [Full Text] [Related]

  • 13. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.
    Tankovic J, Perichon B, Duval J, Courvalin P.
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2505-10. PubMed ID: 8913454
    [Abstract] [Full Text] [Related]

  • 14. Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus.
    Takahata M, Yonezawa M, Kurose S, Futakuchi N, Matsubara N, Watanabe Y, Narita H.
    J Antimicrob Chemother; 1996 Sep; 38(3):543-6. PubMed ID: 8889728
    [Abstract] [Full Text] [Related]

  • 15. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones.
    Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM.
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2498-506. PubMed ID: 12121924
    [Abstract] [Full Text] [Related]

  • 16. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus.
    Ferrero L, Cameron B, Crouzet J.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1554-8. PubMed ID: 7492103
    [Abstract] [Full Text] [Related]

  • 17. Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains.
    Wang T, Tanaka M, Sato K.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):236-40. PubMed ID: 9527766
    [Abstract] [Full Text] [Related]

  • 18. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.
    Tankovic J, Duval J, Courvalin P.
    FEMS Immunol Med Microbiol; 1994 Jun; 9(1):35-9. PubMed ID: 7920462
    [Abstract] [Full Text] [Related]

  • 19. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus.
    Soussy CJ, Wolfson JS, Ng EY, Hooper DC.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2588-92. PubMed ID: 8109921
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME.
    Am J Med; 1989 Nov 30; 87(5A):2S-8S. PubMed ID: 2574005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.